TNXP icon

Tonix Pharmaceuticals
TNXP

Overview Fund Trends Analyst Outlook Journalist POV

23 hedge funds and large institutions have $11.1M invested in Tonix Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more ownership

Funds ownership: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

57% less capital invested

Capital invested by funds: $25.7M → $11.1M (-$14.6M)

Holders
23
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$5.05M
2
+$1.37M
3
+$712K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$250K
5
Millennium Management
Millennium Management
New York
+$222K

Top Sellers

1
-$1.18M
2
-$1.15M
3
-$375K
4
Nuveen Asset Management
Nuveen Asset Management
Illinois
-$315K
5
Bank of New York Mellon
Bank of New York Mellon
New York
-$305K
Name Holding Trade Value Shares
Change 		Change in
Stake
51
–
52
–
53
–
54
–
55
–
56
–
57
–
58
–
59
–
60
–
61
–
62
–
63
–
64
–
65
–
66
–
67
–
68
–
69
–
70
–
71
–
72
–
73
–
74
–
75
–
1 2
3
4